AstraZeneca (NYSE:AZN) recently reported that it has filed a lawsuit against the US Food and Drug Administration (FDA) in the US District Court for the District of Columbia to overturn the FDA?s denial on March 7, 2012 of the company?s Citizen Petitions with regard to SEROQUEL® (quetiapine fumarate) tablets and SEROQUEL XR® (quetiapine fumarate) extended release tablets.

*****************

CRWE, Crown Equity Holdings Inc., CRWE.OB

CRWE offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them.

CRWE?s advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness.

CRWE?s subsidiary Crown Tele Services Inc. is a provider of affordable, world class (VoIP) communications solutions .

The number one priority for many businesses is to spend less.

Cutting business costs can be tricky, but one place you can be sure to maximize savings without sacrificing quality is in your phone system. How? Through VoIP communications.

Voice over Internet Protocol (VoIP) technology offers businesses an unbeatable proposition: streamline telecommunications while reducing total cost of ownership. VoIP integrates business communications into a single infrastructure: the data network. From small businesses to large enterprises, VoIP users report increased productivity, flexibility, and lower bills.

Overall, the telecommunications industry estimates that businesses cut their telecommunications costs by about 30% when they switch to VoIP.

More about CRWE at www.crownequityholdings.com.

*****************

Enzo Biochem Inc. (NYSE:ENZ) recently reported the filing of an application with the New York State Department of Health for the first assay based on its proprietary AmpiProbe(TM) nucleic acid detection platform.

Upon approval, the Company plans to market its HCV RNA Quantification Assay for viral load determination through its Enzo Clinical Laboratory. The Company previously announced plans to seek CE-IVD designation for this assay in order to make it available as a diagnostic product in the European Union.

*****************

Codexis, Inc. (NASDAQ:CDXS), a developer of industrial enzymes to enable the production of biofuels, bio-based chemicals, and pharmaceutical intermediates, reported that Peter Strumph, interim Chief Executive Officer, will be presenting at the Sidoti & Company 16th Annual Emerging Growth Institutional Investor Forum, to be held in New York, NY on Tuesday, March 20, 2012 at 2:40 p.m. ET at The Grand Hyatt New York.

***************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.